Showing results (111-120 of 1,406) with videos related to

Sort By:
Pageof 141
Open Heart|June 3, 2016
Health utility indexes in patients with acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
Journal of the American Heart Association|November 8, 2019
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting StentsJuan F Iglesias, Dik Heg, Marco Roffi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2017
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trialsSalvatore Cassese, Robert A Byrne, Peter Jüni, et al.
Plos One|December 10, 2014
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary interventionThomas Pilgrim, Martina Rothenbühler, Bindu Kalesan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 27, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.
Circulation|June 8, 2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trialLorenz Räber, Lea Wohlwend, Mathias Wigger, et al.
European Heart Journal|October 12, 2017
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summaryRobert A Byrne, Giulio G Stefanini, Davide Capodanno, et al.
Circulation|July 22, 2009
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisStéphane Cook, Elena Ladich, Gaku Nakazawa, et al.
Pageof 141